Companies

Artiva Biotherapeutics, Inc. (ARTV) SEC filings

CIK 0001817241 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024
Revenue (USD)033.5 M
Net income (USD)-83.9 M-28.7 M
Diluted EPS (USD/shares)-3.43-35.78

Latest filings

FiledFormDescriptionPeriod
2026-10-07442026-10-06
2026-10-06144144
2026-10-06442026-10-05
2026-10-06442026-10-05
2026-10-06442026-10-05
2026-10-06442026-10-05
2026-09-15442026-09-15
2026-09-14442026-09-10
2026-09-14442026-09-10
2026-09-14442026-09-10
2026-09-14442026-09-10
2026-09-14442026-09-10
2026-09-14442026-09-10
2026-09-14442026-09-10
2026-09-14442026-09-10
2026-09-11442026-09-09
2026-09-11442026-09-09
2026-09-11442026-09-09
2026-09-11442026-09-09
2026-09-11S-8S-8
2026-09-118-K8-K items 5.02,5.07,9.012026-09-08
2026-09-09442026-09-08
2026-09-08442026-09-08
2026-09-08442026-09-08
2026-09-08442026-09-08

Forms on file (last 1,000): 4 99, 3 22, 8-K 21, 144 13, 10-Q 7, CORRESP 5, S-1/A 5, S-8 4. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=ARTV (0.002 USD), /gw/filings/filings?ticker=ARTV&form=8-K, /gw/filings/facts?ticker=ARTV&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange